The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older individuals worldwide. The disease is characterized by abnormal extracellular deposits, known as drusen, that accumulate along the basal surface of the retinal pigmented epithelium. Although drusen deposition is common in older individuals, large numbers of drusen and/or extensive areas of confluent drusen represent a significant risk factor for AMD. Widespread drusen deposition is associated with retinal pigmented epithelial cell dysfunction and degeneration of the photoreceptor cells of the neural retina. Recent studies have shown that drusen contain a variety of immunomodulatory molecules, suggesting that the process of drusen formation involves local inflammatory events, including activation of the complement cascade. Similar observations in Alzheimer's disease (AD) have lead to the hypothesis that chronic localized inflammation is an important element of AD pathogenesis, with significant neurodegenerative consequences. Accordingly, the amyloid beta (Aβ) peptide, a major constituent of neuritic plaques in AD, has been implicated as a primary activator of complement in AD. Here we show that Aβ is associated with a substructural vesicular component within drusen. Aβ colocalizes with activated complement components in these “amyloid vesicles,” thereby identifying them as potential primary sites of complement activation. Thus, Aβ deposition could be an important component of the local inflammatory events that contribute to atrophy of the retinal pigmented epithelium, drusen biogenesis, and the pathogenesis of AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen (Johnson et al., 2002).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Johnson et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Bustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citationMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Self-citationNormal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Self-citationAccumulation of cholesterol with age in human Bruch's membrane.
Curcio, C. A., Millican, C. L., Bailey, T. A., & Kruth, H. S. (2001) · PubMed · Cited by 508
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Research works printed but not linked: 9
- G S Hageman, P J Luthert, N H V Chong, L V Johnson, D H Anderson, R F Mullins Progr. Ret. Eye Res., eds N N Osborne, G J Chader (Elsevier Science, London) 20, 705–732 (2001).
- H Lin, D O Clegg Invest Ophthalmol Visual Sci 39, 1703–1712 (1998).
- K S Kim, D L Miller, V J Sapienza, C M J Chen, C Bai, I Grundke-Iqbal, J R Currie, H M Wisniewski Neurosci Res Comm 2, 121–130 (1988).
- K S Kim, G Y Wen, C Bancher, C M J Chen, V J Sapienza, H Hong, H M Wisniewski Neurosci Res Commun 7, 113–122 (1990).
- D A Simpson, S Feeney, C Boyle, A W Stitt Mol Vis 6, 178–183 (2000).
- C A Curcio, C L Millican, T Bailey, H S Kruth Invest Ophthalmol Visual Sci 42, 265–274 (2001).
- K Loeffler, D Edward, M Tso Invest Ophthalmol Visual Sci 36, 24–31 (1995).
- R P Burns, L Feeney-Burns Trans Am Ophthalmol Soc 78, 206–225 (1980).
- R J Ulshafer, C B Allen, B Nicolaissen, M L Rubin Invest Ophthalmol Visual Sci 28, 683–689 (1987).
Cited by
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationThe retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,403
Current concepts in the pathogenesis of age-related macular degeneration
Zarbin, M. A. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.598 · Cited by 1,006
Anderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G., et al. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.11.003 · Cited by 727
Self-citationDrusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Inflammation and its role in age-related macular degeneration
Kauppinen, A., Paterno, J. J., Blasiak, J., Salminen, A., & Kaarniranta, K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2147-8 · Cited by 649
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 631
Self-citationCombadière, C., Feumi, C., Raoul, W., Keller, N., Rodéro, M., Pézard, A., Lavalette, S., Houssier, M., Jonet, L., Picard, E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31692 · Cited by 618
At the interface of sensory and motor dysfunctions and Alzheimer’s disease.
Albers, M. W., Gilmore, G. C., Kaye, J., Murphy, C., Wingfield, A., Bennett, D. A., Boxer, A. L., Buchman, A. S., Cruickshanks, K. J., Devanand, D. P., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.514 · Cited by 589
Immunology of age-related macular degeneration
Ambati, J., Atkinson, J. P., & Gelfand, B. D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3459 · Cited by 584
Molecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582
“Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen (Johnson et al., 2002).”
BackgroundThe dynamic nature of Bruch's membrane
Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F., & Bergen, A. A. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.003 · Cited by 581
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease
Koronyo, Y., Biggs, D., Barron, E., Boyer, D. S., Pearlman, J. A., Au, W. J., Kile, S. J., Blanco, A., Fuchs, D.-T., Ashfaq, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93621 · Cited by 510
The Role of Inflammation in the Pathogenesis of Age-related Macular Degeneration
Donoso, L. A., Kim, D., Frost, A., Callahan, A., & Hageman, G. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.12.001 · Cited by 483
Proteome-based plasma biomarkers for Alzheimer's disease
Hye, A., Lynham, S., Thambisetty, M., Causevic, M., Campbell, J., Byers, H. L., Hooper, C., Rijsdijk, F., Tabrizi, S. J., Banner, S., et al. (2006) · Brain · doi:10.1093/brain/awl279 · Cited by 464
Holz, F. G., Strauss, E. C., Schmitz-Valckenberg, S., & van Lookeren Campagne, M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.023 · Cited by 402
Photochemical Damage of the Retina
Wu, J., Seregard, S., & Algvere, P. V. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.06.009 · Cited by 396
Parainflammation, Chronic Inflammation and Age-Related Macular Degeneration
Chen, M., & Xu, H. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0615-239r · Cited by 381
“as AGEs [101–103], b-amyloid [104, 105], pyridinium bisretinoid”
Targeting amyloid-β in glaucoma treatment
Guo, L., Salt, T. E., Luong, V., Wood, N., Cheung, W., Maass, A., Ferrari, G., Russo-Marie, F., Sillito, A. M., Cheetham, M. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703707104 · Cited by 342
Anderson, D. H., Talaga, K. C., Rivest, A. J., Barron, E., Hageman, G. S., & Johnson, L. V. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2003.10.011 · Cited by 319
Self-citationSoft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies
Curcio, C. A. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-24882 · Cited by 318
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 316
Age‐related Macular Degeneration (AMD)
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_5059 · Cited by 314
Amyloid-β Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease
Ning, A., Cui, J., To, E., Ashe, K. H., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1849 · Cited by 303
Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging
Fournet, M., Bonté, F., & Desmoulière, A. (2018) · Aging and disease · doi:10.14336/ad.2017.1121 · Cited by 291
Curcio, C. A., Johnson, M., Huang, J.-D., & Rudolf, M. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.001 · Cited by 286
Reinisalo, M., Kårlund, A., Koskela, A., Kaarniranta, K., & Karjalainen, R. O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/340520 · Cited by 284
Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging
Bowes Rickman, C., Farsiu, S., Toth, C. A., & Klingeborn, M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12757 · Cited by 282
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
“…activators, complement components, and complement regulatory proteins are constituents of both drusen (Anderson et al., 2010; Hageman et al., 2005; Johnson et al., 2002, 2001, 2006; Mullins et al., 2000; Nozaki et al., 2006; Umeda et al., 2005; Wang et al., 2010) and senile plaques (Eikelenboom…”
BackgroundInfluentialDentchev, T., Milam, A. H., Lee, V. M. Y., Trojanowski, J. Q., & Dunaief, J. L. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00804-3 · Cited by 274
Hahn, P. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.8.1099 · Cited by 258
Miller, J. W. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.10.018 · Cited by 250
Photoreceptor cell death and rescue in retinal detachment and degenerations
Murakami, Y., Notomi, S., Hisatomi, T., Nakazawa, T., Ishibashi, T., Miller, J. W., & Vavvas, D. G. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.08.001 · Cited by 247
Wooff, Y., Man, S. M., Aggio-Bruce, R., Natoli, R., & Fernando, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01618 · Cited by 246
Murakami, K., Murata, N., Noda, Y., Tahara, S., Kaneko, T., Kinoshita, N., Hatsuta, H., Murayama, S., Barnham, K. J., Irie, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279208 · Cited by 241
Chiu, S. J., Izatt, J. A., O'Connell, R. V., Winter, K. P., Toth, C. A., & Farsiu, S. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-7640 · Cited by 239
Macular degeneration: recent advances and therapeutic opportunities
Rattner, A., & Nathans, J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2007 · Cited by 231
Age related macular degeneration and drusen: Neuroinflammation in the retina
Buschini, E., Piras, A., Nuzzi, R., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.011 · Cited by 230
The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer's Brain and Retinal Disease
Sivak, J. M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10827 · Cited by 220
The Eye As a Biomarker for Alzheimer's Disease
Lim, J. K. H., Li, Q.-X., He, Z., Vingrys, A. J., Wong, V. H. Y., Currier, N., Mullen, J., Bui, B. V., & Nguyen, C. T. O. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00536 · Cited by 209
Drusen-Associated Degeneration in the Retina
Johnson, P. T., Lewis, G. P., Talaga, K. C., Brown, M. N., Kappel, P. J., Fisher, S. K., Anderson, D. H., & Johnson, L. V. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0436 · Cited by 208
Self-citationNeovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
Ricci, F., Bandello, F., Navarra, P., Staurenghi, G., Stumpp, M., & Zarbin, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218242 · Cited by 208
Luibl, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25843 · Cited by 203
The potential role of amyloid in the pathogenesis of age-related macular degeneration
Yoshida, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24635 · Cited by 202
Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202
Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration
Curcio, C. A., Johnson, M., Huang, J.-D., & Rudolf, M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r002238 · Cited by 200
Zareparsi, S., Buraczynska, M., Branham, K. E. H., Shah, S., Eng, D., Li, M., Pawar, H., Yashar, B. M., Moroi, S. E., Lichter, P. R., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi154 · Cited by 190
Ding, J.-D., Johnson, L. V., Herrmann, R., Farsiu, S., Smith, S. G., Groelle, M., Mace, B. E., Sullivan, P., Jamison, J. A., Kelly, U., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100901108 · Cited by 188
Self-citationSenescence in the pathogenesis of age-related macular degeneration
Blasiak, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03420-x · Cited by 183
Abecasis, G. R., Yashar, B. M., Zhao, Y., Ghiasvand, N. M., Zareparsi, S., Branham, K. E. H., Reddick, A. C., Trager, E. H., Yoshida, S., Bahling, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/382786 · Cited by 182
Manczak, M., Kandimalla, R., Fry, D., Sesaki, H., & Reddy, P. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw330 · Cited by 179
Persistent remodeling and neurodegeneration in late-stage retinal degeneration
Pfeiffer, R. L., Marc, R. E., & Jones, B. W. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.004 · Cited by 178
Javaid, F. Z., Brenton, J., Guo, L., & Cordeiro, M. F. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00055 · Cited by 178
Neuroprotection in glaucoma – Is there a future role?
Baltmr, A., Duggan, J., Nizari, S., Salt, T. E., & Cordeiro, M. F. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.08.009 · Cited by 177
Therapeutic targets in age-related macular disease
Bird, A. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42437 · Cited by 175
Gharbiya, M., Trebbastoni, A., Parisi, F., Manganiello, S., Cruciani, F., D'Antonio, F., De Vico, U., Imbriano, L., Campanelli, A., & De Lena, C. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-132039 · Cited by 174
Amyloid beta mediates memory formation
Garcia-Osta, A., & Alberini, C. M. (2009) · Learning & Memory · doi:10.1101/lm.1310209 · Cited by 171
Vitreous fluid levels of β-amyloid(1–42) and tau in patients with retinal diseases
Yoneda, S., Hara, H., Hirata, A., Fukushima, M., Inomata, Y., & Tanihara, H. (2005) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-004-0156-x · Cited by 170
Immunopathological aspects of age-related macular degeneration
Patel, M., & Chan, C.-C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 164
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163
Structure, Function, and Pathology of Bruch's Membrane
Curcio, C. A., & Johnson, M. (2013) · Retina · doi:10.1016/b978-1-4557-0737-9.00020-5 · Cited by 161
Complement factor H in AMD: Bridging genetic associations and pathobiology
Toomey, C. B., Johnson, L. V., & Bowes Rickman, C. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.001 · Cited by 161
Self-citationStrategies for the Inhibition of Protein Aggregation in Human Diseases
Bartolini, M., & Andrisano, V. (2010) · ChemBioChem · doi:10.1002/cbic.200900666 · Cited by 159
Alzheimers Disease and Retinal Neurodegeneration
Guo, L., Duggan, J., & Cordeiro, M. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274491 · Cited by 158
Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration
Kersten, E., Paun, C. C., Schellevis, R. L., Hoyng, C. B., Delcourt, C., Lengyel, I., Pető, T., Ueffing, M., Klaver, C. C. W., Dammeier, S., et al. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2017.05.003 · Cited by 156
Amyloid-β immunisation for Alzheimer's disease
Wisniewski, T., & Konietzko, U. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70170-4 · Cited by 155
Hajrasouliha, A. R., Jiang, G., Lu, Q., Lü, H., Kaplan, H. J., Zhang, H., & Shao, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470765 · Cited by 155
Sadowski, M., Pankiewicz, J., Scholtzova, H., Ripellino, J. A., Li, Y., Schmidt, S. D., Mathews, P. M., Fryer, J. D., Holtzman, D. M., Sigurdsson, E. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63355-x · Cited by 154
“This process can be effectively promoted by A pathological chaperone proteins (for review, see(3)) such as apolipoprotein E (apoE), especially its E4 isoform,(4) 1-antichymotrypsin (ACT),(5) or C1q complement factor.(6) They promote formation of A fibrils, which remain sequestered within the brain and accumulate in th…”
BackgroundAlber, J., Goldfarb, D., Thompson, L. I., Arthur, E., Hernandez, K., Cheng, D., DeBuc, D. C., Cordeiro, F., Provetti‐Cunha, L., den Haan, J., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12006 · Cited by 154
Dementia of the eye: the role of amyloid beta in retinal degeneration
Ratnayaka, J. A., Serpell, L. C., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.100 · Cited by 153
Soluble and Mature Amyloid Fibrils in Drusen Deposits
Isas, J. M., Luibl, V., Johnson, L. V., Kayed, R., Wetzel, R., Glabe, C. G., Langen, R., & Chen, J. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4207 · Cited by 153
Self-citationLiu, R. T., Gao, J., Cao, S., Sandhu, N., Cui, J. Z., Chou, C. L., Fang, E., & Matsubara, J. A. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10849 · Cited by 152
Fujihara, M., Nagai, N., Sussan, T. E., Biswal, S., & Handa, J. T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003119 · Cited by 150
Nordgaard, C. L., Berg, K. M., Kapphahn, R. J., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0976 · Cited by 149
High concentration of zinc in sub-retinal pigment epithelial deposits
Lengyel, I., Flinn, J. M., Pető, T., Linkous, D. H., Cano, K., Bird, A. C., Lanzirotti, A., Frederickson, C. J., & van Kuijk, F. J. G. M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.12.015 · Cited by 141
Zarbin, M. A., & Rosenfeld, P. J. (2010) · Retina · doi:10.1097/iae.0b013e3181f57e30 · Cited by 140
Mechanism of Inflammation in Age-Related Macular Degeneration
Parmeggiani, F., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., D’Angelo, S., Perri, P., De Palma, P., De Nadai, K., & Sebastiani, A. (2012) · Mediators of Inflammation · doi:10.1155/2012/546786 · Cited by 135
Neuroprotection in Glaucoma: Drug‐Based Approaches
Cheung, W., Guo, L., & Cordeiro, M. F. (2008) · Optometry and Vision Science · doi:10.1097/opx.0b013e31817841e5 · Cited by 132
Wong, J. H. C., Jessica, Y. W., Jobling, A. I., Brandli, A. A., Greferath, U., Fletcher, E. L., & Vessey, K. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1009599 · Cited by 132
Hoh Kam, J., Lenassi, E., & Jeffery, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013127 · Cited by 131
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease
Zhou, J., Fonseca, M. I., Pisalyaput, K., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05558.x · Cited by 130
Modulation of three key innate immune pathways for the most common retinal degenerative diseases
Akhtar‐Schäfer, I., Wang, L., Krohne, T. U., Xu, H., & Langmann, T. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708259 · Cited by 129
Alzheimer’s Retinopathy: Seeing Disease in the Eyes
Mirzaei, N., Shi, H., Oviatt, M., Doustar, J., Rentsendorj, A., Fuchs, D.-T., Sheyn, J., Black, K. L., Koronyo, Y., & Koronyo-Hamaoui, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00921 · Cited by 128
Czakó, C., Kovács, T., Ungvari, Z., Csiszar, A., Yabluchanskiy, A., Conley, S., Csipo, T., Lipecz, A., Horváth, H., Sándor, G. L., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00252-7 · Cited by 126
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
Patel, N., Ohbayashi, M., Nugent, A. K., Ramchand, K., Toda, M., Chau, K., Bunce, C., Webster, A., Bird, A. C., Ono, S. J., et al. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02173.x · Cited by 125
Yamada, Y., Ishibashi, K., Ishibashi, K., Bhutto, I. A., Tian, J. Y., Lutty, G. A., & Handa, J. T. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.005 · Cited by 116
Lechner, J., Chen, M., Hogg, R. E., Toth, L., Silvestri, G., Chakravarthy, U., & Xu, H. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0060-5 · Cited by 114
Amyloid‐β(1‐42) alters structure and function of retinal pigmented epithelial cells
Bruban, J., Glotin, A., Dinet, V., Chalour, N., Sennlaub, F., Jonet, L., An, N., Faussat, A. M., & Mascarelli, F. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00456.x · Cited by 114
Zhou, J., Cai, B., Jang, Y. P., Pachydaki, S., Schmidt, A. M., & Sparrow, J. R. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.11.009 · Cited by 113
Baldacci, F., Lista, S., Cavedo, E., Bonuccelli, U., & Hampel, H. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1304217 · Cited by 113
Nonvascular retinal imaging markers of preclinical Alzheimer's disease
Snyder, P. J., Johnson, L. N., Lim, Y. Y., Santos, C. Y., Alber, J., Maruff, P., & Fernández, B. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.09.001 · Cited by 112
Self-citationRecharging mitochondrial batteries in old eyes. Near infra-red increases ATP
Gkotsi, D., Begum, R., Salt, T. E., Lascaratos, G., Hogg, C. R., Chau, K., Schapira, A. H. V., & Jeffery, G. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.02.023 · Cited by 112
Inflammation and Age-Related Macular Degeneration (AMD)
Telander, D. G. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.570849 · Cited by 110
Ding, J., Lin, J. C., Mace, B. E., Herrmann, R., Sullivan, P. M., & Rickman, C. B. (2007) · Vision Research · doi:10.1016/j.visres.2007.07.025 · Cited by 109
Sundstrom, J. M., Hernández, C., Weber, S. R., Zhao, Y., Dunklebarger, M., Tiberti, N., Laremore, T. N., Simó‐Servat, O., García‐Ramírez, M., Barber, A. J., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23678 · Cited by 109
Renzi‐Hammond, L. M., Dengler, M. J., Puente, A. N., Miller, L. S., & Hammond, B. R. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.024 · Cited by 107
Ocular Biomarkers for Early Detection of Alzheimer's Disease
Frost, S., Martins, R. N., & Kanagasingam, Y. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100819 · Cited by 106
Kijlstra, A., La Heij, E. C., & Hendrikse, F. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940590909185 · Cited by 106
Age-Related Macular Degeneration
Khandhadia, S., Cherry, J., & Lotery, A. J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_2 · Cited by 106
Wang, J., Ohno‐Matsui, K., Yoshida, T., Shimada, N., Ichinose, S., Sato, T., Mochizuki, M., & Morita, I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21742 · Cited by 105
Metadata
- Authors
- Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H.
- Affiliations
- University of California, Santa Barbara (US)
- Johns Hopkins University (US)
- ORCID
- Radeke, Monte J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-20
- Volume
- 99
- Issue
- 18
- Pages
- 11830-11835
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC129354
- OpenAlex
- W2003101845
- Cited by
- 447
- References
- 45
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 14 · 2023: 8 · 2022: 17 · 2021: 20 · 2020: 20 · 2019: 14 · 2018: 19 · 2017: 26 · 2016: 24 · 2015: 34 · 2014: 38 · 2013: 21 · 2012: 23
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY011521, EY 11-521, R01EY011527, EY11527)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- amyloid-beta, complement activation, age-related macular degeneration, drusen, retinal pigment epithelium, neuroinflammation, retinal aging, neuritic plaques, complement proteins
- MeSH terms
- Aged, Aged, 80 and over, Aging, Base Sequence, Complement Activation, Humans, Immunohistochemistry, Macular Degeneration, Middle Aged, Polymerase Chain Reaction, Amyloid beta-Peptides, DNA Primers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.